121 – 130 of 376
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2011
-
Mark
Most 70- to 79-year-old patients with acute myeloid leukemia do benefit from intensive treatment.
(
- Contribution to journal › Letter
-
Mark
CD146 expression on primary nonhematopoietic bone marrow stem cells is correlated with in situ localization
(
- Contribution to journal › Article
-
Mark
Presence of FLT3-ITD and high BAALC expression are independent prognostic markers in childhood acute myeloid leukemia
(
- Contribution to journal › Article
-
Mark
IL-7 mediates Ebf-1-dependent lineage restriction in early lymphoid progenitors
(
- Contribution to journal › Article
-
Mark
Secondary autoimmune diseases occurring after HSCT for an autoimmune disease: a retrospective study of the EBMT Autoimmune Disease Working Party
(
- Contribution to journal › Article
-
Mark
Risk of acute myeloid leukemia and myelodysplastic syndromes after multiple myeloma and its precursor disease (MGUS)
(
- Contribution to journal › Article
-
Mark
Activated protein C cofactor function of protein S: a novel role for a gamma-carboxyglutamic acid residue
(
- Contribution to journal › Article
-
Mark
Results from a randomized trial of salvage chemotherapy followed by lestaurtinib for patients with FLT3 mutant AML in first relapse
(
- Contribution to journal › Article
-
Mark
Complement activation on platelet-leukocyte complexes and microparticles in enterohemorrhagic Escherichia coli-induced hemolytic uremic syndrome.
(
- Contribution to journal › Article
-
Mark
Joining the stem cell maintenance squad.
(
- Contribution to journal › Article